In preceding papers, we discussed the laccase-catalyzed amination of 2,5-dihydroxybenzoic acid derivatives with aminopenicillins and aminocephalosporins.
In preceding papers, we discussed the laccase-catalyzed amination of 2,5-dihydroxybenzoic acid derivatives with aminopenicillins and aminocephalosporins. 2, 3) The motive for our work was the global issue with resistant pathogenic bacteria, e.g. Streptococcus pneumoniae strains [4] [5] [6] [7] and Staphylococcus strains, against currently available b-lactam antibiotics. [8] [9] [10] [11] Aminated products like 2-(3,6-dioxocyclohexa-1,4-dienylamino)-2-phenyl-acetylamino-penicillanic acids and 2-(3,6-dioxocyclohexa-1,4-dienylamino)-2-phenyl-acetylamino-cephalosporanic acids 2, 3) inhibited the growth of several Gram positive bacterial strains and protected mice against an infection with Staphylococcus aureus. After amination the 2,5-dihydroxybenzoic acid derivatives were units of the C-7 substituent of the b-lactam antibiotics.
The possibility of utilizing catechol units as an element of the C-7 substituent of penicillins and cephalosporins was investigated for a long time. [12] [13] [14] [15] [16] [17] Through the tonB dependent iron transport mechanism, 18) the use of catechol substituted b-lactams was known to increase the drug's penetration into the bacterial cell walls. Thus, several catechol-substituted blactams have been synthesized and showed good antimicrobial activities. [19] [20] [21] [22] [23] As a consequence of the promising activity of the catechol substituted b-lactams on one hand and the novel laccase-synthesized b-lactams on the other hand, we got interested in laccase-catalyzed amination of catechols with aminopenicillins and aminocephalosporins.
In this study, we have employed laccase from Trametes sp. to derivatize amino-b-lactams and to couple them both with catechol and with substituted catechols. The novel b-lactams were structurally characterized as new coupling products inhibiting the growth of several Gram positive bacterial strains in the agar diffusion assay, among them methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci. The cytotoxicity of the new compounds and the effectiveness in a "Staphylococcus-infected, immune suppressed mouse" model are discussed.
Results and Discussion
Biotransformation of Amino-b b-lactams by Laccases
Laccase-catalyzed reaction between catechols (substrates 1a to 1c) on one hand and the amino-b-lactams cefadroxil 2a, amoxicillin 2b, ampicillin 2c, and the structurally related carbacephem loracarbef 2d on the other hand led to cross coupled products (Table 1) . 3-Methylcatechol and amino-b-lactams were consumed after an incubation time of 1.5 h, and monoaminated products (3a to 3d) were detectable by high-performance liquid chromatography (HPLC). If other catechols or longer reaction times were used, monoaminated products were only obtained in low yields and undesirable side reactions produced a number of by-products. Reaction kinetics similar to these findings were described for hybrid dimer formation from 3,4-dichloroaniline and syringic acid 24) or 3-(3,4-dihydroxy-phenyl)-propionic acid and 4-aminobenzoic acid. 25) In contrast, for hybrid dimer formation from 2,5-dihydroxybenzoic acid derivatives with aminopenicillins and aminocephalosporins, 2, 3) amino acids, 26) and primary aromatic amines, 27, 28) we found straightforward biotransformations. Therefore the amination of 2,5-dihydroxybenzoic acid derivatives with laccase from Trametes sp. is an excellent method for the synthesis of novel b-lactams whereas the amination of catechols is limited to a few specific educts (Fig. 1) . 
After separation of the products 3a to 3e by solid phase extraction, mass spectral analyses (LC/MS with API-ES positive modes) of the compounds showed a molecular mass attributed to the coupling of methylcatechol (1a or 1b) with one amino-b-lactam (2a to 2d) under loss of four hydrogen atoms indicating a quinonoid structure of the products. Furthermore, 1 H-NMR spectral data of 3a to 3e contained the characteristic signals for both substrates (1a, 1b) and educts (2a to 2d). The number of CH proton signals of the dihydroxylated phenyl rings changed from three-in the substrates-to two signals-in the products. The multiplicity of the two signals of the product indicated a further substituent at the C1Љ. HMBC spectra measured in DMSO showed two typical correlations for quinones in the range of 180 ppm. This is an important indication for the quinonoid character of 3a to 3e, confirming the oxidation of catechols to quinones similar to the hybrid dimer quinones formed from 2,5-dihydroxybenzoic acid derivatives with penicillins, 2) amino acids, 26) and primary aromatic amines, 27, 28) and for the hybrid dimer quinones produced from 3,4-dichloraniline with protocatechuic acid and syringic acid. 24, 29) Although 3a to 3e have quinone units as an element of the C-7 or C-6 substituent instead of catechol units these products should also have biological activity because of the described activities of other ortho-quinonoid [30] [31] [32] or para-quinonoid [33] [34] [35] substances. Biological Activity of the Biotransformation Products Growth inhibition of the new b-lactam antibiotics 3a to 3e against Gram positive strains was determined by the agar diffusion method according to Burkhardt, 36) and the results for selected strains-among them multidrug resistant Staphylococcus and Enterococcus strains-are summarized in Table  2 . The growth inhibition values of cefadroxil, amoxicillin, ampicillin, and loracarbef (2a to 2d) and the catechol derivatives are also presented for comparison. 3b and 3c showed balanced antibacterial activity against all Gram positive strains except against S. epidermidis 535 which is strongly resistant to penicillin and cephalosporin families. The new ortho-quinonoid substituted penicillins (3b, 3c) showed more potent activity against the tested strains than the new orthoquinonoid substituted cephalosporin and carbacephem derivatives (3a, 3d, 3e) comparable with the results of the paraquinonoid substituted penicillins, 2) cephalosporins, and carbacephems.
3) Investigations towards the stability of the synthesized compounds showed limited lifetime in aqueous solution. Incubation at 30°C of solutions of 3a to 3e showed decomposition after 2 h. Therefore the survey of the antimi- crobial effects was concentrated on the initial screening using the agar diffusion test.
Cytotoxicity of the new b-lactam antibiotics (3a to 3e) and of cefadroxil, amoxicillin, ampicillin, and loracarbef (2a to 2d) was determined by the neutral red uptake assay 37) using FL-cells, a human amniotic epithelial cell line (Table 3) . Whereas 3a was not cytotoxic against FL cells in concentrations tested, 3b to 3e showed slight cytotoxicity. Remarkable is the fact, that the methylcatechol substrates were strong cytotoxic in all concentrations tested whereas cytotoxicity of products (3b to 3e) were comparable low, but not negligible. Aminopenicillins and aminocephalosporins synthesized by amination of 2,5-dihydroxybenzoic acid derivatives showed no or only weak cytotoxicity against FL cells in concentrations up to 100 mg/ml.
2,3)
A "Staphylococcus-infected, immune suppressed mouse" 904 Vol. 56, No. 7 model was used for the examination of in vivo effectiveness against Gram positive strains of in vitro active products (Table 4 ). 30 to 60% of the mice treated i.p. with biotransformation products survived the infection with Staphylococcus aureus ATCC 6538, whereas all untreated mice died after infection within 2 d. But all mice treated with cefadroxil and amoxicillin survived the infection with Staphylococcus aureus ATCC 6538 without any noticeable problems, whereas the mice treated with biotransformation products showed symptoms of intoxication. In contrast to these results we reported on para-quinonoid substituted penicillins, 2) cephalosporins and carbacephems, 3) which protected mice against an infection with Staphylococcus aureus without any hints of intoxication. Of the two series of cephalosporins and penicillins, the ones bearing para-quinonoid structures 2, 3) showed more potent activity in protecting mice against an infection with Staphylococcus aureus than another with orthoquinonoid structures (3a to 3e), possibly due to the different cytotoxicity.
Concluding, the activity in vivo of the novel penicillins and cephalosporins with ortho-quinonoid structure is unsatisfactory because of the cytotoxicity based on the orthoquinonoid structure. But the laccase-catalyzed amination of catechols with aminopenicillins and aminocephalosporins is a new method to synthesize novel penicillins and cephalosporins by enzymatic transformation. These reactions represent new, low-cost processes, which allow the use of mild reaction conditions, aqueous solvent systems, normal pressure, and room temperature. Further advantage is the specificity of the reaction, which can comprise the amination of para-and ortho-dihydroxylated aromatic compounds 2, 3, 25, 27, 28) on one hand and the combination of two antibiotics containing a phenol moiety, 38) the introduction of a phenolic compound into an antibiotic containing a phenolic moiety, 39) and the oxidation of an antibiotic 40) on the other hand. In summary it can be concluded that the laccase has a high potential for the synthesis of new antibiotic substances. Further studies are in progress.
Experimental
Enzymes Extracellular laccase C of Trametes sp. (EC 1.10.3.2) was obtained from ASA Spezialenzyme (Wolfenbüttel, Germany) and used in an activity of 800 nmol · ml Ϫ1 · min Ϫ1 (substrate: 2,2Ј-amino-bis-3-ethylbenzthiazoline-6-sulfonic acid).
Chemicals Chemicals were purchased from commercial suppliers: cefadroxil, cefaclor and cefalexin from Sigma-Aldrich Germany, loracarbef from Eli Lilly Germany, 2,5-dihydroxy-N-(2-hydroxyethyl)benzamide from Midori Kagaku Co., Japan, 2,5-dihydroxybenzoic acid methyl ester and 2,5-dihydroxybenzoic acid ethyl ester from Sigma-Aldrich. All chemicals were used as received. 2,5-Dihydroxybenzamide was synthesized as described previously.
28)
Conditions of Biotransformation b-Lactam antibiotics [2a to 2d (13 mg)] were dissolved in 15 ml sodium acetate buffer, 20 mM pH 5.6. After addition of laccase C (activity 800 nmol · ml Ϫ1 · min Ϫ1 ), the reaction mixtures were completed by a solution of 5 mg catechols (1a to 1c) in 5 ml sodium acetate buffer, pH 5.6. The reaction mixtures were incubated for 5 h at room temperature with agitation at 400 rpm.
For preparative scale the same procedure was used as described above apart from lager amount of educts [1a (31 mg in 25 ml for production of 3a, 9.9 mg in 10 ml for production of 3b, 37 mg in 25 ml for production of 3c, 44 mg in 25 ml for production of 3d), 1b (31 mg in 25 ml for production of 3e), 2a, 2d (58 mg in 75 ml), 2b (26 mg in 30 ml), 2c (49 mg in 75 ml)] and shorter reaction time (1.5 h).
Analytical High-Performance Liquid Chromatography (HPLC) For routine analysis, samples of the incubation mixture were analyzed by an HPLC system (Dionex, Idstein, Germany) consisting of a Gynkotek High Precision Pump Model 480, Dionex ASI-100 Automated Sample-Injector, Dionex UVD 340S Diode-Array-Detector, and Chromeleon Version 6.30. An endcapped, 5-mm, LiChroCart 125-4 RP 18 column (Merck, Darmstadt, Germany) was used. A solvent system consisting of methanol (eluent A) and phosphoric acid, 0.1% pH 2 (eluent B), starting from an initial ratio of 10% A and 90% B and reaching 100% A within 14 min, was used at a flow rate of 1 ml/min.
Procedure for Isolation of Biotransformation Products
After activation and equilibration, an RP18 silicagel column (20 cc, 5 g absorbent material, Waters, Manchester, U.K.) was charged with the incubation mixture. The column was washed twice with 20 ml of a mixture of methanol (10%) and distilled water (90%). The products were eluted with 10 ml acetonitrile. The acetonitrile eluates were dried using a vacuum rotator at 30°C.
Characterization of Biotransformation Products Products were analyzed by mass spectrometry (LC/MS with API-ES in positive modes).
The nuclear magnetic resonance (NMR) spectra were obtained at 600 MHz ϩ API-ES pos. mode). Methyl-3,4-dioxocyclohexa-1,5-dienylamino)-2-phenyl-acetylamino] -penicillanic Acid 3c Synthesis and isolation as described above. 8 cells-on 20 ml medium). The following bacterial strains were used: Staphylococcus aureus ATCC 6538 and S. aureus Norddeutscher Epidemiestamm. Besides these the agents were tested against the following multidrug resistant strains isolated from patients: S. aureus 315, S. aureus 36881, S. aureus 38418, S. aureus 520, S. epidermidis 125, S. epidermidis 535, S. epidermidis 847, and Enterococcus faecalis 769. The test samples were applied in different concentrations on sterile paper discs (Sensi-Disc, 6 mm diameter, Becton Dickinson Microbiology systems). Test concentrations were selected according to the concentration of the standard antibiotics (cefadroxil, amoxicillin, ampicillin, and loracarbef) on the Sensi discs. Plates were kept for 3 h in a refrigerator to enable prediffusion of the substances into the agar and were then incubated for 24 h at 37°C. Average inhibition zone diameters were calculated from 3 replicates.
6-[2-(5-
Cytotoxic Activity The cytotoxicity was determined by the neutral red uptake assay 37) using FL-cells, a human amniotic epithelial cell line. The test allows the differentiation between dead and living cells on the fact that only living cells are able to manage the active uptake of neutral red. FL-cells were cultivated in a 96-well microtiter plate (10 5 cells/ml Hepes modified Dulbecco, Sigma, 150 ml/well) at 37°C in a humidified 5% carbon dioxide atmosphere. The Dulbecco's Modified Eagle's Medium (DMEM) was completed by L-glutamin (1%, Sigma), penicillin G/streptomycin (1%, Sigma) and FCS (10%, Biocrom). After 24 h 50 ml of the test solution (test substance dissolved in 20 ml DMSO under stirring in an ultrasonic bath for 5 min and then diluted with 1 ml medium) or medium with equal amounts of DMSO (control) were added. After a further incubation for 72 h cells were washed three times with phosphate buffered saline solution (PBS). One hundred microliter neutral red solution (Sigma, 0.3% in DMEM) was added per well. The cells were then incubated for 3 h at 37°C, followed by another three times washing with PBS. A solution (100 ml) of acetic acid (1%, v/v) and ethanol (50%, v/v) in distilled water were added. After shaking for 15 min the optical density was measured at 492 nm with a Micro Screener LB 9260 (EG&G Berthold, Bad Wildbad, Germany). The mean of three measurements for each concentration was determined (nϭ3).
Animal Assays A "Staphylococcus-infected, immune suppressed mouse" model was established for the examination of in vivo effectiveness of in vitro selected drugs. In this model 8-weeks old female BALB/C mice (3 mice/group/assay) were pre-treated with cyclophosphamide (250 mg/kg intraperitoneal (i.p.) day Ϫ3 and 100 mg/kg i.p. day Ϫ1, Sigma) to suppress the immune answer. Three days later they were infected with Staphylococcus aureus ATCC 6538, i.p., in a lethal dose (10 10 -10 12 colony forming units). The test agents were injected 30 min and 6 h after the infection with Staphylococcus aureus ATCC 6538. The concentration of the test agents was selected according to therapeutically used doses of ampicillin. The antibiotic effectiveness was recognised within the next 2-6 d.
